Exact Mass: 512.1997
Exact Mass Matches: 512.1997
Found 500 metabolites which its exact mass value is equals to given mass value 512.1997
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Physalin M
Physalin M belongs to the class of organic compounds known as physalins and derivatives. These are steroidal constituents of Physalis plants which possess an unusual 13,14-seco-16,24-cyclo-steroidal ring skeleton (where the bond that is normally present between the 13 and 14 positions in other steroids is broken while a new bond between positions 16 and 24 is formed). Physalin M is an extremely weak basic (essentially neutral) compound (based on its pKa). Physalin M is found in fruits. Physalin M is a constituent of Physalis alkekengi (winter cherry). Constituent of Physalis alkekengi (winter cherry). Physalin M is found in fruits.
sialosyl-Tn saccharide
(2R)-8-methylsocotrin-4-ol
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone
(1R*,2S*,4S*,4S*,6S*,7R*,8R*,9S*,10S*,11Z,14S*,17S*)-14-acetoxy-6-chloro-4,8-epoxy-9,17-dihydroxy-2-propionyloxybriara-5(16),11-dien-18-one
6-(2,6-dihydroxy-4-methoxy-3-methyl-benzhydryl)-5,7-dihydroxy-8-methyl-2-phenyl-chroman-4-one|isomelanervin
1,2alpha-dehydro-3beta,4beta-dioxolan-daphnetoxin-21-one|genkwanin I
(2RS,3RS)-2,3,4,5-tetrahydro-3-(3-hydroxy-5-methoxyphenyl)-2-(4-hydroxy-3-methoxyphenyl)-10-methoxyphenanthro[2,1-b]furan-7-ol|phochinenin F
naphthalene-1,8-diol 1,8-bis(4-O-methyl-beta-glucopyranoside)|naphthalene-1,8-diyl bis(4-O-methyl-beta-glucopyranoside)
2,2-dimethyl-2H-(8-hydroxy-6-acetyl)-[2,3-b]-pyran-8-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
11-oxo-7alpha-obacunyl acetate|11-Oxo-7??-obacunyl acetate
Loperamide hydrochloride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist[1][2][3]. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect[4].
C24H32O12_Cyclopenta[c]pyran-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,6-dihydroxy-7-methyl-, 2-(4-hydroxyphenyl)ethyl ester
C26H28N2O9_14H-Pyrano[3,4:6,7]indolizino[1,2-b]quinoline-11,14(3H)-dione, 4-ethenyl-3-(beta-D-glucopyranosyloxy)-4,4a,5,5a,6,12-hexahydro-, (3S,4R,4aS,5aS)
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_major
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_49.7\\%
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_88.5\\%
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_47.5\\%
Ala Glu Met Tyr
Ala Glu Tyr Met
Ala Met Glu Tyr
Ala Met Tyr Glu
Ala Tyr Glu Met
Ala Tyr Met Glu
Cys Asp Ile Tyr
Cys Asp Leu Tyr
Cys Asp Tyr Ile
Cys Asp Tyr Leu
Cys Glu Val Tyr
Cys Glu Tyr Val
Cys Phe Phe Pro
Cys Phe Ile Met
Cys Phe Leu Met
Cys Phe Met Ile
Cys Phe Met Leu
Cys Phe Pro Phe
Cys Ile Asp Tyr
Cys Ile Phe Met
Cys Ile Met Phe
Cys Ile Tyr Asp
Cys Leu Asp Tyr
Cys Leu Phe Met
Cys Leu Met Phe
Cys Leu Tyr Asp
Cys Met Phe Ile
Cys Met Phe Leu
Cys Met Ile Phe
Cys Met Leu Phe
Cys Pro Phe Phe
Cys Val Glu Tyr
Cys Val Tyr Glu
Cys Tyr Asp Ile
Cys Tyr Asp Leu
Cys Tyr Glu Val
Cys Tyr Ile Asp
Cys Tyr Leu Asp
Cys Tyr Val Glu
Asp Cys Ile Tyr
Asp Cys Leu Tyr
Asp Cys Tyr Ile
Asp Cys Tyr Leu
Asp Phe Met Thr
Asp Phe Thr Met
Asp His Asn Gln
Asp His Gln Asn
Asp Ile Cys Tyr
Asp Ile Tyr Cys
Asp Leu Cys Tyr
Asp Leu Tyr Cys
Asp Met Phe Thr
Asp Met Thr Phe
Asp Asn His Gln
Asp Asn Gln His
Asp Gln His Asn
Asp Gln Asn His
Asp Thr Phe Met
Asp Thr Met Phe
Asp Tyr Cys Ile
Asp Tyr Cys Leu
Asp Tyr Ile Cys
Asp Tyr Leu Cys
Glu Ala Met Tyr
Glu Ala Tyr Met
Glu Cys Val Tyr
Glu Cys Tyr Val
Glu Phe Met Ser
Glu Phe Ser Met
Glu His Met Pro
Glu His Asn Asn
Glu His Pro Met
Glu Met Ala Tyr
Glu Met Phe Ser
Glu Met His Pro
Glu Met Pro His
Glu Met Ser Phe
Glu Met Tyr Ala
Glu Asn His Asn
Glu Asn Asn His
Glu Pro His Met
Glu Pro Met His
Glu Ser Phe Met
Glu Ser Met Phe
Glu Thr Thr Tyr
Glu Thr Tyr Thr
Glu Val Cys Tyr
Glu Val Tyr Cys
Glu Tyr Ala Met
Glu Tyr Cys Val
Glu Tyr Met Ala
Glu Tyr Thr Thr
Glu Tyr Val Cys
Phe Cys Phe Pro
Phe Cys Ile Met
Phe Cys Leu Met
Phe Cys Met Ile
Phe Cys Met Leu
Phe Cys Pro Phe
Phe Asp Met Thr
Phe Asp Thr Met
Phe Glu Met Ser
Phe Glu Ser Met
Phe Phe Cys Pro
Phe Phe Pro Cys
Phe Ile Cys Met
Phe Ile Met Cys
Phe Leu Cys Met
Phe Leu Met Cys
Phe Met Cys Ile
Phe Met Cys Leu
Phe Met Asp Thr
Phe Met Glu Ser
Phe Met Ile Cys
Phe Met Leu Cys
Phe Met Ser Glu
Phe Met Thr Asp
Phe Pro Cys Phe
Phe Pro Phe Cys
Phe Ser Glu Met
Phe Ser Met Glu
Phe Thr Asp Met
Phe Thr Met Asp
Gly His His Tyr
Gly His Asn Trp
Gly His Trp Asn
Gly His Tyr His
Gly Asn His Trp
Gly Asn Trp His
Gly Trp His Asn
Gly Trp Asn His
Gly Tyr His His
His Asp Asn Gln
His Asp Gln Asn
His Glu Met Pro
His Glu Asn Asn
His Glu Pro Met
His Gly His Tyr
His Gly Asn Trp
His Gly Trp Asn
His Gly Tyr His
His His Gly Tyr
His His Tyr Gly
His Met Glu Pro
His Met Pro Glu
His Asn Asp Gln
His Asn Glu Asn
His Asn Gly Trp
His Asn Asn Glu
His Asn Gln Asp
His Asn Trp Gly
His Pro Glu Met
His Pro Met Glu
His Gln Asp Asn
His Gln Asn Asp
His Trp Gly Asn
His Trp Asn Gly
His Tyr Gly His
His Tyr His Gly
Ile Cys Asp Tyr
Ile Cys Phe Met
Ile Cys Met Phe
Ile Cys Tyr Asp
Ile Asp Cys Tyr
Ile Asp Tyr Cys
Ile Phe Cys Met
Ile Phe Met Cys
Ile Met Cys Phe
Ile Met Phe Cys
Ile Tyr Cys Asp
Ile Tyr Asp Cys
Leu Cys Asp Tyr
Leu Cys Phe Met
Leu Cys Met Phe
Leu Cys Tyr Asp
Leu Asp Cys Tyr
Leu Asp Tyr Cys
Leu Phe Cys Met
Leu Phe Met Cys
Leu Met Cys Phe
Leu Met Phe Cys
Leu Tyr Cys Asp
Leu Tyr Asp Cys
Met Ala Glu Tyr
Met Ala Tyr Glu
Met Cys Phe Ile
Met Cys Phe Leu
Met Cys Ile Phe
Met Cys Leu Phe
Met Asp Phe Thr
Met Asp Thr Phe
Met Glu Ala Tyr
Met Glu Phe Ser
Met Glu His Pro
Met Glu Pro His
Met Glu Ser Phe
Met Glu Tyr Ala
Met Phe Cys Ile
Met Phe Cys Leu
Met Phe Asp Thr
Met Phe Glu Ser
Met Phe Ile Cys
Met Phe Leu Cys
Met Phe Ser Glu
Met Phe Thr Asp
Met His Glu Pro
Met His Pro Glu
Met Ile Cys Phe
Met Ile Phe Cys
Met Leu Cys Phe
Met Leu Phe Cys
Met Met Met Thr
Met Met Thr Met
Met Pro Glu His
Met Pro His Glu
Met Ser Glu Phe
Met Ser Phe Glu
Met Thr Asp Phe
Met Thr Phe Asp
Met Thr Met Met
Met Tyr Ala Glu
Met Tyr Glu Ala
Asn Asp His Gln
Asn Asp Gln His
Asn Glu His Asn
Asn Glu Asn His
Asn Gly His Trp
Asn Gly Trp His
Asn His Asp Gln
Asn His Glu Asn
Asn His Gly Trp
Asn His Asn Glu
Asn His Gln Asp
Asn His Trp Gly
Asn Asn Glu His
Asn Asn His Glu
Asn Gln Asp His
Asn Gln His Asp
Asn Trp Gly His
Asn Trp His Gly
Pro Cys Phe Phe
Pro Glu His Met
Pro Glu Met His
Pro Phe Cys Phe
Pro Phe Phe Cys
Pro His Glu Met
Pro His Met Glu
Pro Met Glu His
Pro Met His Glu
Gln Asp His Asn
Gln Asp Asn His
Gln His Asp Asn
Gln His Asn Asp
Gln Asn Asp His
Gln Asn His Asp
Ser Glu Phe Met
Ser Glu Met Phe
Ser Phe Glu Met
Ser Phe Met Glu
Ser Met Glu Phe
Ser Met Phe Glu
Thr Asp Phe Met
Thr Asp Met Phe
Thr Glu Thr Tyr
Thr Glu Tyr Thr
Thr Phe Asp Met
Thr Phe Met Asp
Thr Met Asp Phe
Thr Met Phe Asp
Thr Met Met Met
Thr Thr Glu Tyr
Thr Thr Tyr Glu
Thr Tyr Glu Thr
Thr Tyr Thr Glu
Val Cys Glu Tyr
Val Cys Tyr Glu
Val Glu Cys Tyr
Val Glu Tyr Cys
Val Tyr Cys Glu
Val Tyr Glu Cys
Trp Gly His Asn
Trp Gly Asn His
Trp His Gly Asn
Trp His Asn Gly
Trp Asn Gly His
Trp Asn His Gly
Tyr Ala Glu Met
Tyr Ala Met Glu
Tyr Cys Asp Ile
Tyr Cys Asp Leu
Tyr Cys Glu Val
Tyr Cys Ile Asp
Tyr Cys Leu Asp
Tyr Cys Val Glu
Tyr Asp Cys Ile
Tyr Asp Cys Leu
Tyr Asp Ile Cys
Tyr Asp Leu Cys
Tyr Glu Ala Met
Tyr Glu Cys Val
Tyr Glu Met Ala
Tyr Glu Thr Thr
Tyr Glu Val Cys
Tyr Gly His His
Tyr His Gly His
Tyr His His Gly
Tyr Ile Cys Asp
Tyr Ile Asp Cys
Tyr Leu Cys Asp
Tyr Leu Asp Cys
Tyr Met Ala Glu
Tyr Met Glu Ala
Tyr Thr Glu Thr
Tyr Thr Thr Glu
Tyr Val Cys Glu
Tyr Val Glu Cys
10S,11R-epoxy-punaglandin 3
Physalin M
ST 26:8;O7
α-D-Galactopyranose, 2-(acetylamino)-6-O-(N-acetyl-β-neuraminosyl)-2-deoxy
Nalfurafine hydrochloride
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
Taladegib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
(4bS,6aS,7S,9aS,9bS)-N-[2,5-Bis(trifluoromethyl)phenyl]-6a-methyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine
2-Hydroxy-2-methyl-1-phenyl-propan-1-one-2,4,6-Trimethylbenzoyldiphenyl-phosphine oxide mixture
Talmapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
3-(9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
N-[2-[4-(4-methoxyphenyl)-1-piperazinyl]ethyl]-6-sulfanylidene-5H-benzimidazolo[1,2-c]quinazoline-3-carboxamide
19-Ethenyl-18-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-2(11),4,6,8,15-pentaene-10,14-dione
[(10S,12S,13E,14R,16S,18R)-13-ethylidene-14-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6,8-tetraen-18-yl] acetate
N-[3-[butyl(ethyl)amino]propyl]-2-[6-(4-morpholinylsulfonyl)-3-oxo-1,4-benzothiazin-4-yl]acetamide
4-(10-Methyl-8-phenyl-6-phenylamino-8,11-dihydro-5,7,8,9,11a-pentaaza-cyclopenta[b]phenanthren-11-yl)-benzene-1,2-diol
[4-(3-Chlorophenyl)-1-piperazinyl]-[1-[4-(2-pyridinyl)-1-piperazinyl]-4-isoquinolinyl]methanone
Glu-Thr-Thr-Tyr
A tetrapeptide composed of L-glutamic acid, two L-threonine units and L-tyrosine joined in sequence by peptide linkages.
N-acetyl-beta-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
An amino disaccharide composed of N-acetylneuraminic acid and N-acetyl-alpha-D-galactosamine residues linked (2->6).
(2R)-2-[(4S,5R)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-8-phenyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-D-galacto-hexopyranose
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
(2S,4S,5R,6R)-5-Acetamido-2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
An amino disaccharide composed of N-acetylneuraminic acid and 2-(acetylamino)-2-deoxy-alpha-D-galactopyranose residues in (alpha-2->6) linkage.
(2s)-6-[(1r)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)propyl]-2-(4-hydroxyphenyl)-8-methyl-3,4-dihydro-2h-1-benzopyran-7-ol
(1r)-2-[(3r)-3-acetyl-2,2-dimethyl-6-oxopyran-3-yl]-1-[(1r,3s,6s,7s,11s)-6-(furan-3-yl)-7,11-dimethyl-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-11-yl]ethyl acetate
(z,2z,4e)-n-[(1e)-3-[(8e)-10,17-dihydroxy-7,11-dimethyl-1,5-dioxo-4,7,10,13-tetrahydro-3h-2,6-benzodioxacyclopentadecin-3-yl]prop-1-en-1-yl]-4-(methoxyimino)but-2-enimidic acid
6,14-dihydroxy-10-oxo-4,12-bis(2-oxoheptyl)-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-5-carboxylic acid
(1r,3s,4s,5z,7r,8r)-3-hydroxy-5-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1,3-dimethyl-7-[(1e)-prop-1-en-1-yl]-8-[(5r)-2,4,5-trihydroxy-3,5-dimethyl-6-oxocyclohexa-1,3-diene-1-carbonyl]bicyclo[2.2.2]octane-2,6-dione
12-(2,3-dihydroxy-3-methylbutyl)-5,8,9-trihydroxy-7-(4-hydroxy-3-methylbut-2-en-1-yl)-2,2-dimethyl-1,11-dioxatetracen-6-one
7a,11b-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-5a,8,8,11a-tetramethyl-7,12-dihydro-6h-2,5-dioxatetraphene-1,11-dione
9,10-bis(4-hydroxy-2-methoxyphenyl)-7-methyl-8,9,9a,10-tetrahydro-5bh-1,11-dioxatetraphen-2-one
5,13,17-trihydroxy-7-(2-oxoheptyl)-17-pentyl-2,10,16-trioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),3(8),4,6,11,13-hexaene-9,15-dione
4,6-dihydroxy-3-[(6-hydroxy-1-oxo-3-pentylisochromen-8-yl)oxy]-2-(2-oxoheptyl)benzoic acid
11-oxo-7α-obacunyl acetate
{"Ingredient_id": "HBIN000499","Ingredient_name": "11-oxo-7\u03b1-obacunyl acetate","Alias": "NA","Ingredient_formula": "C28H32O9","Ingredient_Smile": "CC(=O)OC1CC2C(OC(=O)C=CC2(C3C1(C45C(O4)C(=O)OC(C5(CC3=O)C)C6=COC=C6)C)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16387","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-(3,4-dimethoxybenzoyl)-ajugol
{"Ingredient_id": "HBIN012580","Ingredient_name": "6-o-(3,4-dimethoxybenzoyl)-ajugol","Alias": "NA","Ingredient_formula": "C24H32O12","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C4=CC(=C(C=C4)OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6204","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}